News › Clinical Practice, Industry News, Patient Care

Vollure: The New 18-Month Filler

May 5, 2017

Juvéderm Vollure XC — It’s the first FDA-approved hyaluronic acid dermal filler for the correction of moderate to severe wrinkles and folds that lasts up to 18 months. And according to Michele S. Green, M.D., a cosmetic dermatologist in private practice in New York City, it’s revolutionary.
“These results are much better than I expected,” Dr.  Green tells Cosmetic Surgery Times. “The effect lasted so much longer than I thought it would. The duration of many aesthetic products in real life is less than what is claimed. To have a dermal filler last a solid 18 months is pretty revolutionary.”
Vollure uses Allergan’s proprietary VYCROSS technology, which, according to the company, blends various molecular weights of hyaluronic acid (HA) to help the gel achieve an impressive 18 months of duration on average.
Read more at Cosmetic Surgery Times >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Hims & Hers Plans Launch of Peptide Treatments Following Federal Policy Shift
    • FDA Requires New Safety Warning on GLP-1 Medications for Rare Eye Condition
    • Stella Advisory Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics Reports Aesthetic Treatment Satisfaction in Patients Using GLP-1s
    • Menopause and Aesthetics: What Medical Spas Need to Know About Skin Changes
Advertisement